Materials and Methods: 1684 patients (pts) consecutively enrolled 9/2014 to 7/2015 in 96 Institutions were submitted to a structured interview to record comorbidities and drugs assumption. The severity of comorbidities was measured with the Cumulative Illness Rating Scale (CIRS). Quality of life (QoL) was assessed by the SF-12 questionnaire (PCS = Physical and MCS = Mental Component Summary) and through the Italian UCLA P Ca Index (Function/Bother: UF,UB=Urinary , SF,SB=Sexual , BF,BB=Bowel ). Differences between pts enrolled by Urology [URO] and Radiation Oncology Centers [RO] were assessed with logistic regression and/or general linear models. Purpose or Objective: TME surgery, with or without preoperative (chemo-)radiotherapy is the standard of care in patients with resectable rectal cancer. In patients unfit for surgery, radiotherapy alone is often used with palliative intent. However, complete response can be achieved when high doses are administered. In this study we examined the feasibility of external beam radiotherapy (EBRT) followed by an endorectal brachytherapy boost in elderly patients, unfit for surgery. Primary results, presented at ESTRO 2014, are now complemented with response assessment and long-term FU at 3 years.
Results

Material and Methods:
A dose finding feasibility study was performed from 2007 to 2013 in two hospitals in inoperable rectal cancer patients. Treatment consisted of EBRT (13x3
